“We now plan to file an IND within the next few weeks to begin studies of PRO 140 for the treatment of colon carcinoma. We will also continue to explore the biological pathways involving CCR5 to identify other potential therapeutic opportunities for PRO 140.”
Good results
Do they have money to start another trial in Cancer? Hopefully the trial will be managed by hospital and CYDY will supply the drug.
News 
Market Data 
Discover 
